Low levels of 1,25(OH)2D levels in the body can lead to deterioration of the RAS system by inducing abnormal metabolic profiles such as increasing renin, proteinuria, blood pressure, insulin resistance, and renal injury (34–36). This evidence concerns the gene REN and Insulin resistance.